Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
28 studies found for:    " May 16, 2007":" June 15, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Buprenorphine, Tipranavir and ritonavir
2 Completed Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
Condition: HIV Infections
Intervention: Biological: MRKAd5 HIV-1 gag/pol/nef
3 Completed Project HERMITAGE: HIV Prevention in Hospitalized Russian Drinkers
Condition: HIV Infections
Interventions: Behavioral: Individual and group HIV risk behavior counseling sessions;   Behavioral: health education and support group
4 Unknown  RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients
Condition: HIV Infections
Intervention: Behavioral: rice based food supplement
5 Completed Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
Condition: HIV Infection
Intervention: Biological: tgAAC09
6 Completed Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1
Condition: HIV Infections
Intervention: Procedure: lumbar puncture, MRI, MRS
7 Completed Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r
Condition: HIV Infections
Intervention: Genetic: identify genetic polymorphism in Thai HIV infected
8 Completed Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs
Condition: HIV Infections
Intervention: Procedure: salvage therapy
9 Active, not recruiting
Has Results
Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Raltegravir poloxamer film coated tablet;   Drug: Raltegravir chewable tablet;   Drug: Raltegravir oral granules for suspension (20 mg/mL)
10 Completed A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China
Condition: HIV Infections
Interventions: Behavioral: HIV skills training;   Behavioral: Popular Opinion Leaders training
11 Completed A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects
Condition: HIV Infections
Intervention: Drug: efavirenz
12 Completed Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
Condition: HIV Infections
Intervention: Biological: GenHevac B Pasteur
13 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Highly active antiretroviral treatment (HAART)
14 Completed A PK and Salvage Study for Children With HIV-infection
Condition: HIV Infections
Intervention: Drug: Lopinavir/r plus saquinavir
15 Completed Effects of Creatine and Resistance Exercise Training in People With HIV Infection
Condition: HIV Infections
Interventions: Procedure: Use of creatine monohydrate (a dietary supplement);   Behavioral: Progressive resistance exercise training
16 Completed Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: HAART containing nevirapine
17 Completed Phase 1 Safety Study of Two Experimental HIV Vaccines
Conditions: AIDS Vaccines;   HIV Infections;   HIV-1
Interventions: Drug: VRC-HIVADV027-00-VP;   Drug: VRC-HIVADV038-00-VP
18 Completed A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Conditions: HIV Infections;   TB
Intervention: Biological: MVA 85A
19 Completed Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: nevirapine
20 Completed Safety Study of IL-7 in HIV-infected Patients (Inspire)
Conditions: HIV Infections;   Lymphopenia
Intervention: Drug: CYT 107

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.